bms
Our Medicines Contact Us Careers
United States
Americas

Argentina

Spanish

Brazil

Portuguese

Canada

English French

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English

Venezuela

Spanish
Asia Pacific

Australia

English

China

Simplified Chinese

India

English

Japan

Japanese

Korea

Korean

New Zealand

English

Taiwan

Traditional Chinese
Europe

Austria

German

Belgium

English Dutch French

Czech Republic

English

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

Dutch

Norway

Norwegian

Poland

Polish

Portugal

English

Romania

Romanian

Russia

Russian

Spain

Spanish

Sweden

Swedish

Switzerland

German French

United Kingdom

English
Middle East

Saudi Arabia

English Arabic

Turkey

Turkish

United Arab Emirates

English Arabic
Other

Other Markets

Distributor Markets
Our Medicines
Patients & Caregivers
Our medicines
Get help paying for your medicine
Patient resources
Immunology Patient Resources
Risk Evaluation and Mitigation Strategies (REMS)

FEATURED

Get Help Paying For Your Medicine
  • Get Help Paying For Your Medicine >

Healthcare Providers
Pre-Approval Access to Investigational Medicines
Investigational drugs available
340B Distribution Practice Fact Sheet

FEATURED

Annual Report 2021
  • Annual Report 2021 >

Researchers
Areas of Focus
Our research in Immunology
In the pipeline
Our R&D team
Researcher bios
Research Publications
"Golden Ticket" Contests
Translational Medicine
Clinical Trials & Research
Disclosure Commitment
Independent Research
Investigator Sponsored Research Portal
Areas of Interest & Competitive Research Grants
Compound & Technology Requests
Data Sharing Request Process
The Thomas O. Daniel Research Incubator and Collaboration Center
About Incubator and Collaboration Center
Application Process and Criteria
Frequently Asked Questions
Contact Us

FEATURED

Area of Focus
  • Area of Focus >

Investors
Stock information
Dividend history
Stock split history
Investment return calculator
Financial reporting
SEC filings
Quarterly Results
Product Sales summary
Annual Reports
Analyst coverage
Events and presentations
Shareholder Services
Annual Meeting of Shareholders
Cost Basis calculator
Acquisition FAQs for Celgene Shareholders
Acquisition-related information for Celgene shareholders
Tax Implications of Celgene Acquisition
Acquisition FAQs for Celgene Shareholders
Investor contacts
Investor Alerts Subscribe
Investor Alerts Unsubscribe
RSS feeds

FEATURED

Annual Report 2021
  • Annual Report 2021 >

Business Development
Our Partnerships
Why Partner With Us
Areas of Interest
Business Development Leadership Team
Begin a Discussion
Global Alliances leadership team

FEATURED

Download Business Development Brochure
  • Download Business Development Brochure >

News
Press Releases
RSS Feeds
Unsubscribe to News Email Alerts - Bristol Myers Squibb
Subscribe to New Email Alerts - Bristol Myers Squibb
Life & Science Stories
All
People
Science
News & Perspectives
Life & Science Stories Alert Subscription
Life & Science Stories Alerts Unsubscribe
Medical Meetings
BMS at June 2022 oncology and hematology congresses
BMS at ACTRIMS Forum 2022
BMS at ECCO 2022
BMS at ASH 2021
Media Library
Scientific Media Resources
Disease State Infographics
Media Contacts

FEATURED

BMS at ASCO and EHA 2022
  • BMS at ASCO and EHA 2022 >

Driving transformative science to advance the future of cancer care for all

About Us
Our company
Our Mission, Vision, Values & Commitment
Our principles
History Timeline
Survivorship Today
Committed to creating a better future for cancer patients
Global Patient Week
Patient & employee stories
Governance
Doing business with us as a supplier
Achievements
Worldwide Locations
Corporate Brand
Leadership
Leadership Team
Board of Directors
People & Business Resource Groups leadership team
Global Diversity and Inclusion
Our Commitments
Global Diversity and Inclusion Report
People & Business Resource Groups
Our Commitment to Equal Employment Opportunity
Giovanni Caforio reflects to Asian American hate crimes
Responsibility
COVID-19 updates
The Bristol Myers Squibb Foundation
Corporate Giving
Independent medical education
Supporting Our Communities
Access to Medicines in the Developing World
Position on Key Issues
Sustainability
Goals & key indicators
Economic responsibility
Governance
Social Progress
Environmental performance
Global Reporting Initiative
Sustainability Resources
Subject Index
Contact Us
Social

FEATURED

Annual Report 2021
  • Annual Report 2021 >

Medicines > Careers > Press Releases > Medical Information >

Life & Science Stories

All
People
Science
News & Perspectives
A subset of BMS.com, Life & Science Stories is our digital magazine where we share the work our global community of colleagues are doing around the world to help patients and advance scientific innovation.
Subscribe for New Story Alerts >
Browse by Topic
  • Advocacy
  • Atrial Fibrillation (AFib)
  • BMS Foundation
  • Beautiful Science
  • Blood & Bone Marrow Cancer
  • COVID-19
  • Cancer
  • Cancer Research
  • Cardiovascular Research
  • Careers
  • Clinical Trial
  • Collaboration
  • Employee Stories
  • Global Diversity and Inclusion
  • Her Perspective
  • Idiopathic Pulmonary Fibrosis
  • Immune-mediated
  • Immunotherapy
  • International
  • Leadership Perspectives
  • Lung Cancer
  • Lymphoma
  • Our Culture
  • Pancreatic Cancer
  • Philanthropy
  • Research and Development
  • Rheumatoid Arthritis (RA)
  • Sustainability
June 23, 2022 Science
Pioneering paths forward in immunology >
June 16, 2022 News & Perspectives
Juneteenth: Remembering the past, reimagining the future >
Clasped hands
May 27, 2022
BMS’ commitment to precision medicine for patients living with immune-mediated diseases >
Kellie Calderon, MD, executive medical director
May 27, 2022
Lupus: Treatments, research and Bristol Myers Squibb’s dedication to patients – A Q&A With Subhashis Banerjee >
Lupus: Treatments, Research and Bristol Myers Squibb’s Dedication to Patients – A Q&A with Subhashis Banerjee
May 24, 2022
Local Cambridge STEM program empowers next generation of female scientists >

News & Perspectives

Take a look at current events and what is impacting the work we do. 
View all news articles >
News & Perspectives
Clasped hands
June 16, 2022
Juneteenth: Remembering the past, reimagining the future >
Lupus: Treatments, Research and Bristol Myers Squibb’s Dedication to Patients – A Q&A with Subhashis Banerjee
May 27, 2022
Lupus: Treatments, research and Bristol Myers Squibb’s dedication to patients – A Q&A With Subhashis Banerjee >
Bristol Myers Squibb facility in Moreton, UK, exemplifies sustainability innovation
April 21, 2022
R&D facility building in the UK exemplifies sustainability innovation >

People

Learn more about how everything we do is for every one of us. 
View all people articles >
People
Kellie Calderon, MD, executive medical director
May 27, 2022
BMS’ commitment to precision medicine for patients living with immune-mediated diseases >
May 24, 2022
Local Cambridge STEM program empowers next generation of female scientists >
Estelle Vester-Blokland ,Global Head of Medical Affairs
March 30, 2022
Meet our Leaders: Estelle Vester-Blokland >

Science

Learn more about our science, the core of our work. 
View all science articles >
Science
June 23, 2022
Pioneering paths forward in immunology >
abder schoenfeld
May 17, 2022
The evolution of lung cancer research >
May 02, 2022
Why is hypertrophic cardiomyopathy, the most commonly inherited heart disease, often undiagnosed? >
Quick Links
  • Home
  • Patients & Caregivers
  • Healthcare Providers
  • Researchers
  • Investors
  • Careers
  • News
Resources
  • Our Medicines
  • Life & Science Stories
  • About Us
  • UK-CA Slavery and Human Trafficking Statement (PDF)
Follow Us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • YouTube
  • Legal Notice
  • Privacy Policy
  • Trademarks
  • Forward-Looking Statement
  • Worldwide Locations
  • Contact Us
June 23, 2022
© 2022 Bristol-Myers Squibb Company